Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Clinical trial NCT00897806 · TERMINATED
Trial details
- NCT number
- NCT00897806
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2002-02-01
- Primary completion
- 2006-02-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.